Alto Neuroscience CFO sells $3.57 million in shares

Alto Neuroscience President and CFO Nicholas Conrad Smith sold 134,886 shares for about $3.57 million in transactions on September 29 and 30, 2026. The sales were made under a Rule 10b5-1 trading plan adopted in June, and included shares sold after Smith exercised employee stock options. Following the transactions, Smith directly held 24,060 shares.
Where do you stand?





